These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Experimental and clinical study of a new immunoregulator preparation thymalin]. Khavinson VKh; Morozov VG Voen Med Zh; 1982 May; (5):37-9. PubMed ID: 7048731 [No Abstract] [Full Text] [Related]
3. Studies on immunotropic activity of certain immunomodulators. Giełdanowski J; Lemmel EE Arch Immunol Ther Exp (Warsz); 1987; 35(2):155-9. PubMed ID: 2451897 [TBL] [Abstract][Full Text] [Related]
4. Linomide induces apoptotic death of cortical CD4/CD8 double positive thymocytes and thymic atrophy by a corticosteroid-independent pathway. Arbel I; Chezen E; Abramsky O; Karpati T; Ovadia H; Mizrachi-Koll R; Karussis D Clin Immunol; 1999 Jan; 90(1):108-14. PubMed ID: 9884358 [TBL] [Abstract][Full Text] [Related]
5. [Clinical effectiveness of T-activin in the treatment of cutaneous forms of lupus erythematosus]. Skripkin IuK; Biriukov AV; Stenina MA; Skripnik AIu; Korotkiĭ NG Vestn Dermatol Venerol; 1985 May; (5):8-11. PubMed ID: 3898631 [No Abstract] [Full Text] [Related]
6. [Current situation of synthetic immunostimulants]. Werner GH Ann Pharm Fr; 1994; 52(2):61-8. PubMed ID: 7944181 [TBL] [Abstract][Full Text] [Related]
7. [Stimulating effect of a polypeptide substance (Cuban stimulator) on hemopoiesis and formation of humoral immunity to murine thymus-dependent antigen]. Shurygin AIa; Zlishcheva EI; Sosnovskaia OIu; Sanin AV Biull Eksp Biol Med; 1995 Nov; 120(11):511-4. PubMed ID: 8713331 [No Abstract] [Full Text] [Related]
9. The role of the thymus in the control of autoimmunity. Heath VL; Saoudi A; Seddon BP; Moore NC; Fowell DJ; Mason DW J Autoimmun; 1996 Apr; 9(2):241-6. PubMed ID: 8738969 [TBL] [Abstract][Full Text] [Related]
10. [Review of study on mechanism of traditional Chinese medicine in treating autoimmunity disease]. Chen Z; Li Y; Li Y Zhong Yao Cai; 2003 Mar; 26(3):218-21. PubMed ID: 12856473 [TBL] [Abstract][Full Text] [Related]
11. Immunomodulation of experimental allergic encephalomyelitis. Arnon R; Teitelbaum D Isr J Med Sci; 1993; 29(2-3):175-81. PubMed ID: 7682204 [No Abstract] [Full Text] [Related]
12. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment. Silver PB; Chan CC; Wiggert B; Caspi RR Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2898-905. PubMed ID: 10549650 [TBL] [Abstract][Full Text] [Related]
14. alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Van Kaer L Nat Rev Immunol; 2005 Jan; 5(1):31-42. PubMed ID: 15630427 [TBL] [Abstract][Full Text] [Related]
15. [Immunocorrective drugs in the combined treatment of autoimmune diseases of the thyroid gland]. Balabolkin MI; Petunina NA; Sakaeva NA Klin Med (Mosk); 1993; 71(6):44-6. PubMed ID: 8145503 [No Abstract] [Full Text] [Related]
17. Immunoregulation of autoimmunity by natural killer T cells. Linsen L; Somers V; Stinissen P Hum Immunol; 2005 Dec; 66(12):1193-202. PubMed ID: 16690406 [TBL] [Abstract][Full Text] [Related]
18. [The effect of a synthetic thymus peptide (thymogen) on the immune system in candidiasis under immunodepression]. Khmel'nitskiĭ OK; Iakovlev GM; Belianin VL; Khavinson VKh; Morozov VG; Deĭgin VI Arkh Patol; 1990; 52(1):20-5. PubMed ID: 2337388 [TBL] [Abstract][Full Text] [Related]
19. Environmental adjuvants, apoptosis and the censorship over autoimmunity. Rovere-Querini P; Manfredi AA; Sabbadini MG Autoimmun Rev; 2005 Nov; 4(8):555-60. PubMed ID: 16214095 [TBL] [Abstract][Full Text] [Related]